Par Health Issues Voluntary Nationwide Recall of Argatroban Injection Due to the Presence of Particulate Matter
Recall from a federal regulator
Headline as published by U.S. Food and Drug Administration (MedWatch) on Oct 14, 2026; collected by the wire Oct 14, 2026, 12:15 PM ET.
FOR IMMEDIATE RELEASE - ROCHESTER, MI– October 13, 2026 – Par Health is recalling 22 lots of Argatroban Injection 250 mg/2.5 mL (100 mg/mL) to the hospital/user level. This recall is being conducted due to the presence of particulate matter, identified as cellulose, polystyrene, polyethylene terepht
Coverage
Topics
- Recalls and safety alertsMatched on
Recall
Explore the named firms, organizations and MDL dockets above. Sources and method